Pretreatment hearing grades and hearing recovery... (2022 study) Skip to main content
Clinical Study Diving and hyperbaric medicine 2022

Pretreatment hearing grades and hearing recovery outcomes after primary hyperbaric oxygen treatment in patients with idiopathic sudden sensorineural hearing loss.

Včeva A, Zubčić Ž, Mihalj H, Maleš J, Mendeš T, Šestak A, Diving and hyperbaric medicine, 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers measured hearing before and after a course of hyperbaric oxygen treatment (HBOT) in 59 people with sudden hearing loss of unknown cause who were treated with HBOT alone.

What They Found

In 59 patients with idiopathic sudden sensorineural hearing loss treated with HBOT only (90 minutes at 203 kPa daily for 20 days), hearing thresholds were significantly lower after treatment than before, with a median recovery of 22.5 dB. The interquartile range was 12.5 to 33.7 dB, and the change was significant across all patients (p less than 0.001). Thresholds were also significantly lower at 500, 1,000, 2,000 and 4,000 Hz (p less than 0.001). The largest change was at 1,000 Hz, a median of 32 dB, but this was not significantly different from the other frequencies (p = 0.10).

What This Means for Canadian Patients

For people with sudden hearing loss of unknown cause, this abstract reports lower hearing thresholds after a 20-day course of HBOT given as the primary treatment. The authors describe HBOT as a legitimate choice for primary treatment, especially if it is readily accessible and if there are contraindications for corticosteroid therapy. The abstract reports no comparison group, so it cannot show how HBOT compares with other treatments.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes a single group of 59 patients who all received HBOT with no comparison group reported, so it cannot show that the hearing improvement was caused by the treatment.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 36100930
Year Published 2022
Journal Diving and hyperbaric medicine
MeSH Terms Hearing; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Retrospective Studies

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology